Profile for South Korea Patent: 102637844
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: 102637844
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,189,833 | May 5, 2036 | Daiichi Sankyo Inc | TURALIO | pexidartinib hydrochloride |
| 10,730,876 | May 5, 2036 | Daiichi Sankyo Inc | TURALIO | pexidartinib hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
